Viewing StudyNCT03559049



Ignite Creation Date: 2024-05-06 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 12:47 PM
Study NCT ID: NCT03559049
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-30
First Post: 2018-06-05

Brief Title: Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
Sponsor: University of Michigan Rogel Cancer Center
Organization: University of Michigan Rogel Cancer Center

Conditions & Keywords Data

Conditions:
Name
Stage IV Non-small Cell Lung Cancer
Keywords: